CDKN2A and urinary bladder cancer: Homozygous deletion at p16 was seen in different stages (T1, NMIBC) and (T2 or more, MIBC) and in different grades of bladder carcinomas, which suggests that the p16 may be involved in the initiation and progression of urinary bladder cancers [56].